M. Schlaich

Most-cited papers

1. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

   K. Ong, Lauryn K. Stafford, Susan A. Mclaughlin, E. Boyko +496 more

   2023The Lancet3,090 citations Open access

   Semantic Scholar

   Save

2. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019

   K. Paulson, Aruna M Kamath, Tahiya Alam, Kelly Bienhoff +496 more

   2021The Lancet341 citations Open access

   Semantic Scholar

   Save

3. Hypertension management in patients with cardiovascular comorbidities.

   L. Lauder, F. Mahfoud, M. Azizi, Deepak L. Bhatt +11 more

   2022European Heart Journal187 citations Open access

   Semantic Scholar

   Save

4. Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

   E. Barbato, M. Azizi, R. Schmieder, L. Lauder +17 more

   2023European Heart Journal136 citations Open access

   Semantic Scholar

   Save

5. Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension

   A. Schutte, T. Jafar, N. Poulter, Albertino A. Damasceno +35 more

   2022Cardiovascular Research135 citations Open access

   Semantic Scholar

   Save

6. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019

   Ewerton Bruce B Caroline Kanyin Liane Theo Cristiana Mohse Cousin Duncan Stein Ong Vos Abbafati Abbasi-Kangev, Ewerton Cousin, B. Duncan, C. Stein +405 more

   2022The Lancet Diabetes and Endocrinology102 citations Open access

   Semantic Scholar

   Save

7. European Society of Hypertension position paper on renal denervation 2021.

   R. Schmieder, F. Mahfoud, G. Mancia, M. Azizi +12 more

   2021Journal of Hypertension94 citations Open access

   Semantic Scholar

   Save

8. International Consensus on Standardized Clinic Blood Pressure Measurement − A Call to Action

   A. Cheung, P. Whelton, P. Muntner, A. Schutte +21 more

   2023American Journal of Medicine88 citations Open access

   Semantic Scholar

   Save

9. Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range.

   F. Mahfoud, G. Mancia, R. Schmieder, L. Ruilope +18 more

   2022Journal of the American College of Cardiology82 citations Open access

   Semantic Scholar

   Save

10. Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension

    G. Sesa-Ashton, J. Nolde, Ida Muente, R. Carnagarin +10 more

    2023HYPERTENSION65 citations Open access

    Semantic Scholar

    Save

11. Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

    E. Barbato, M. Azizi, R. Schmieder, L. Lauder +17 more

    2023EuroIntervention63 citations Open access

    Semantic Scholar

    Save

12. 2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action

    N. Campbell, P. Whelton, M. Orias, R. Wainford +81 more

    2022Journal of Human Hypertension63 citations Open access

    Semantic Scholar

    Save

13. Evaluation of the ability of a commercially available cuffless wearable device to track blood pressure changes

    Isabella Tan, S. Gnanenthiran, J. Chan, K. Kyriakoulis +4 more

    2023Journal of Hypertension60 citations Open access

    Semantic Scholar

    Save

14. Renal denervation in patients with versus without chronic kidney disease: results from the global SYMPLICITY Registry with follow-up data of 3 years.

    C. Ott, F. Mahfoud, G. Mancia, K. Narkiewicz +5 more

    2021Nephrology, Dialysis and Transplantation55 citations

    Semantic Scholar

    Save

15. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation

    R. Carnagarin, Kearney Tan, L. Adams, V. Matthews +6 more

    2021International Journal of Molecular Sciences53 citations Open access

    Semantic Scholar

    Save

16. Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium

    D. Kandzari, F. Mahfoud, Michael A. Weber, R. Townsend +27 more

    2022Circulation50 citations Open access

    Semantic Scholar

    Save

17. Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign

    T. Beaney, Wei Wang, M. Schlaich, A. Schutte +15 more

    2023Journal of Hypertension48 citations Open access

    Semantic Scholar

    Save

18. Device Therapy of Hypertension

    F. Mahfoud, M. Schlaich, M. Lobo

    2021Circulation Research47 citations Open access

    Semantic Scholar

    Save

19. Home blood pressure-centered approach – from digital health to medical practice: HOPE Asia Network consensus statement 2023

    K. Kario, N. Tomitani, Tzung-Dau Wang, Sungha Park +24 more

    2023Hypertension Research38 citations

    Semantic Scholar

    Save

20. Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry

    R. Schmieder, F. Mahfoud, G. Mancia, K. Narkiewicz +8 more

    2022European Heart Journal - Quality of Care and Clinical Outcomes35 citations Open access

    Semantic Scholar

    Save

21. Hypertension in stroke survivors and associations with national premature stroke mortality: data for 2·5 million participants from multinational screening campaigns.

    Queran Lin, Ting Ye, P. Ye, C. Borghi +12 more

    2022Lancet Global Health34 citations Open access

    Semantic Scholar

    Save

22. Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE

    F. Mahfoud, G. Mancia, R. Schmieder, L. Ruilope +11 more

    2023HYPERTENSION32 citations Open access

    Semantic Scholar

    Save

23. Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model

    Andrew S. P. Sharp, S. Tunev, M. Schlaich, David P. Lee +5 more

    2022Journal of Hypertension32 citations Open access

    Semantic Scholar

    Save

24. Determining the role of SGLT2 inhibition with Empagliflozin in the development of diabetic retinopathy

    J. Matthews, L. Herat, J. Rooney, E. Rakoczy +2 more

    2022Bioscience Reports27 citations Open access

    Semantic Scholar

    Save

25. Identifying and treating resistant hypertension in PRECISION: A randomized long‐term clinical trial with aprocitentan

    P. Danaietash, P. Verweij, Ji-Guang Wang, G. Dresser +5 more

    2022The Journal of Clinical Hypertension27 citations Open access

    Semantic Scholar

    Save

26. Implications of ADAM17 activation for hyperglycaemia, obesity and type 2 diabetes

    J. Matthews, Sofia Villescas, L. Herat, M. Schlaich +1 more

    2021Bioscience Reports27 citations Open access

    Semantic Scholar

    Save

27. The urgency to regulate validation of automated blood pressure measuring devices: a policy statement and call to action from the world hypertension league

    J. Sharman, P. Ordunez, T. Brady, G. Parati +16 more

    2022Journal of Human Hypertension26 citations Open access

    Semantic Scholar

    Save

28. Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition

    L. Herat, J. Matthews, O. Azzam, M. Schlaich +1 more

    2022Current Hypertension Reports26 citations Open access

    Semantic Scholar

    Save

29. Lipoprotein (a) and Hypertension

    N. Ward, J. Nolde, J. Chan, R. Carnagarin +2 more

    2021Current Hypertension Reports24 citations

    Semantic Scholar

    Save

30. Plasma lipoprotein subclass variation in middle-aged and older adults: Sex-stratified distributions and associations with health status and cardiometabolic risk factors.

    R. Masuda, Julien Wist, S. Lodge, Torben Kimhofer +11 more

    2023Journal of Clinical Lipidology22 citations Open access

    Semantic Scholar

    Save

31. Multi-organ denervation: a novel approach to combat cardiometabolic disease

    M. Kiuchi, R. Carnagarin, V. Matthews, M. Schlaich

    2023Hypertension Research22 citations Open access

    Semantic Scholar

    Save

32. Determining the Role of SGLT2 Inhibition with Dapagliflozin in the Development of Diabetic Retinopathy.

    L. Herat, J. Matthews, Ong E. Wei, E. Rakoczy +2 more

    2022Frontiers in Bioscience15 citations Open access

    Semantic Scholar

    Save

33. Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy

    R. Carnagarin, J. Nolde, N. Ward, L. M. Lugo-Gavidia +8 more

    2021The Journal of Clinical Hypertension15 citations Open access

    Semantic Scholar

    Save

34. SGLT1/2 inhibition improves glycemic control and multi-organ protection in type 1 diabetes

    L. Herat, J. Matthews, Moira Hibbs, E. Rakoczy +2 more

    2023iScience14 citations Open access

    Semantic Scholar

    Save

35. Global Impact of Different Blood Pressure Thresholds in 4 021 690 Participants of the May Measurement Month Initiative

    J. Nolde, T. Beaney, R. Carnagarin, A. Schutte +2 more

    2022HYPERTENSION14 citations Open access

    Semantic Scholar

    Save

36. May Measurement Month 2019: results of blood pressure screening from 47 countries

    N. Poulter, C. Borghi, Albertino A. Damasceno, T. Jafar +9 more

    2021European Heart Journal, Supplement14 citations Open access

    Semantic Scholar

    Save

37. Efficacy and safety of sodium glucose cotransporter 2 inhibitors plus standard care in diabetic kidney disease: A systematic review and meta-analysis.

    L. Woodhams, L. Chalmers, T. F. Sim, B. Yeap +3 more

    2023Journal of diabetes and its complications13 citations

    Semantic Scholar

    Save

38. Effect of oral contraception on screening tests for primary aldosteronism: a 10-year longitudinal study.

    Jun Yang, S. Gwini, L. Beilin, M. Schlaich +4 more

    2023Journal of Clinical Endocrinology and Metabolism13 citations Open access

    Semantic Scholar

    Save

39. Dual Endothelin Antagonism with Aprocitentan as a Novel Therapeutic Approach for Resistant Hypertension

    Sayeh Heidari Nejad, O. Azzam, M. Schlaich

    2023Current Hypertension Reports13 citations Open access

    Semantic Scholar

    Save

40. Renal, Cardiac, and Autonomic Effects of Catheter-Based Renal Denervation in Ovine Heart Failure

    L. Booth, R. de Silva, R. Pontes, S. Yao +7 more

    2021HYPERTENSION13 citations

    Semantic Scholar

    Save

41. Diabetic kidney disease in type 2 diabetes: a review of pathogenic mechanisms, patient-related factors and therapeutic options

    L. Woodhams, T. F. Sim, L. Chalmers, B. Yeap +4 more

    2021PeerJ13 citations Open access

    Semantic Scholar

    Save

42. Transforming blood pressure control in primary care through a novel Remote Decision Support Strategy based on wearable blood pressure monitoring: The NEXTGEN-BP randomized trial protocol.

    S. Gnanenthiran, Isabella Tan, E. Atkins, A. Avolio +18 more

    2023American Heart Journal12 citations Open access

    Semantic Scholar

    Save

43. The Effect of SGLT2 Inhibition on Diabetic Kidney Disease in a Model of Diabetic Retinopathy

    J. Matthews, M. Schlaich, E. Rakoczy, V. Matthews +1 more

    2022Biomedicines12 citations Open access

    Semantic Scholar

    Save

44. Circulating platelet‐derived extracellular vesicles correlate with night‐time blood pressure and vascular organ damage and may represent an integrative biomarker of vascular health

    L. M. Lugo-Gavidia, R. Carnagarin, D. Burger, J. Nolde +5 more

    2022The Journal of Clinical Hypertension12 citations Open access

    Semantic Scholar

    Save

45. Retinal Capillary Damage is Already Evident in Patients With Hypertension and Prediabetes and Associated With HbA1c Levels in the Nondiabetic Range.

    D. Kannenkeril, J. Nolde, M. Kiuchi, R. Carnagarin +10 more

    2022Diabetes Care11 citations Open access

    Semantic Scholar

    Save

46. Comparing and Contrasting the Effects of the SGLT Inhibitors Canagliflozin and Empagliflozin on the Progression of Retinopathy.

    L. Herat, J. Matthews, E. Rakoczy, M. Schlaich +1 more

    2023Frontiers in Bioscience10 citations Open access

    Semantic Scholar

    Save

47. Cuffless blood pressure devices: the gap between patient acceptability and need for validation

    S. Gnanenthiran, Hueiming Liu, Isabella Tan, J. Chan +2 more

    2022Journal of Hypertension10 citations

    Semantic Scholar

    Save

48. The Relationship Between the Aldosterone-to-Renin Ratio and Blood Pressure in Young Adults: A Longitudinal Study

    Jun Yang, S. Gwini, L. Beilin, M. Schlaich +4 more

    2021Journal of the Endocrine Society10 citations Open access

    Semantic Scholar

    Save

49. Stagnating rates of blood pressure control in Australia: insights from opportunistic screening of 10 046 participants of the May Measurement Month campaigns

    R. Carnagarin, J. Nolde, Jun Yang, F. Marques +8 more

    2023Journal of Hypertension9 citations Open access

    Semantic Scholar

    Save

50. May Measurement Month: results of 12 national blood pressure screening programmes between 2017 and 2019

    N. Poulter, C. Borghi, Albertino A. Damasceno, T. Jafar +10 more

    2022European Heart Journal, Supplement9 citations Open access

    Semantic Scholar

    Save